Director, Cancer Initiatives Professor of Surgery University of South Florida
General Surgery
Dr. Douglas S. Reintgen, MD
|
|
Give Review
Douglas Reintgen is an expert in the field of General Surgery. He graduated from Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine He over the years received 2 awards: "Fellow (FACS)" and "Super Doctor". Douglas S. Reintgen, MD is also published. He has 47 publications published. The lastest publication: "Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy.' Douglas S. Reintgen, MD accepts all Medicare patients.
Publications
- Breast Lymphatic Mapping and Sentinel Lymph Node Biopsy: State of the Art: 2015.
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- Comparison of Sentinel Lymph Node Micrometastatic Tumor Burden Measurements in Melanoma.
- Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
- Evidence for a Better Nodal Staging System for Melanoma: The Clinical Relevance of Metastatic Disease Confined to the Sentinel Lymph Nodes.
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive Breast cancer.
- gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
- The prognostic significance of nonsentinel lymph node metastasis in melanoma.
- Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
- Adherence to the National Quality Forum (NQF) Breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
- Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
- Second primary melanomas: incidence and outcome.
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive Breast cancer: long-term follow-up.
- Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up.
- The number of lymph nodes involved with metastatic Disease does not affect outcome in melanoma patients as long as all Disease is confined to the sentinel lymph node.
- Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
- Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
- Regional node dissection for melanoma: techniques and indication.
- Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database.
- Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
- Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
- Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
- Is incisional biopsy of melanoma harmful?
- Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping.
- The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced Breast cancer receiving neoadjuvant chemotherapy.
- Worldwide experience with lymphatic mapping for invasive Breast cancer.
- An evidence-based staging system for cutaneous melanoma.
- Correlation between prognostic factors and increasing age in melanoma.
- The staging of malignant melanoma and the Florida Melanoma Trial.
- Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma.
- A case report of invasive ductal adenoCarcinoma identified in a lymphatic channel: a staging controversy.
- Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the he...
- Superficial femoral lymph node Dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity.
- Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable Breast cancer.
- Current status of sentinel lymph node mapping and biopsy: facts and controversies.
- New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
- Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive Breast carcinoma and cytokeratin positive only sentine...
- Frequency of nonsentinel lymph node metastasis in melanoma.
- Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with Breast cancer.
- Accurate staging of women with Breast cancer.
- The promise of new technologies and therapies.
- Metastatic melanoma: chemotherapy to biochemotherapy.
- The promise of microarray technology in melanoma care.
- Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy.
Schools
Duke University School Of Medicine
Duke University
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Breast Tumor
- View All
Conditions Treated
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- Colorectal Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Amerigroup (Wellpoint)
- AvMed
- Blue Card PPO
- Blue Care HMO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Wellpath Preferred PPO
- Employer Group Open Access HMO
- Employer Group PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Preferred PPO
- Select HMO
- Tampa Bay CoreNet
- Tampa Bay HUMx HMOx
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
Awards
- Fellow (FACS)
- Super Doctor
Education
-
Duke University Hospital -
Duke University School of Medicine
Hospital
-
Tampa General Hospital
Drug Facts
| NPI NUMBER | 1609869759 | |
| NPPES Provider LastName | REINTGEN | |
| NPPES Provider FirstName | DOUGLAS | |
| NPPES Provider ZIPCode | 336063603 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 84.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 49.0 | |
| Percent Opioid Claims | 58.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609869759 |
| Last Name Of The Provider | REINTGEN |
| First Name Of The Provider | DOUGLAS |
| View All |
Similar Doctors
|
|
Dr. Sylvia D. Campbell, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher Hults, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suneel Khetarpal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juliet C. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather M. Bennett, MD |
|
|
Dr. Francis A. Stratford Jr., MD |
|
|
Dr. Colleen E. Jakey, MD |
|
|
Dr. Cristen N. Litz, MD |